Acute revascularization for ischemic stroke after reversal of dabigatran with idarucizumab: 2 case reports

2 patients (74-year-old male and 89-year-old female) with acute ischemic stroke due to left middle cerebral artery (MCA) occlusion, who were taking dabigatran for atrial fibrillation.

Idarucizumab administration followed by intravenous rt-PA and mechanical thrombectomy.

Safety and clinical outcome (post-operative CT findings for hemorrhagic complications).safety